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ABSTRACT
Objectives: To determine the impact of an educational program on the prevention of central venous 
catheter-related infections in a Brazilian Pediatric Intensive Care Unit. Patients and Methods: All 
patients admitted to the unit between February 2004 and May 2005 were included in the cohort 
study in a longitudinal assessment. An educational program was developed based on the Centers for 
Disease Control and Prevention recommendations for prevention of catheter-associated infections 
and was adapted to local conditions and resources after an initial observational phase. Incidence 
of catheter-associated infections was measured by means of on-site surveillance. Results: One hun-
dred eighteen nosocomial infections occurred in 253 patients (46.6 infections per 100 admissions) 
and in 2,954 patient-days (39.9 infections per 1,000 patient-days). The incidence-density of catheter 
infections was 31.1 episodes per 1.000 venous central catheter-days before interventions, and 16.5 
episodes per 1,000 venous central catheter-days afterwards (relative risk 0.53 [95% CI 0.28-1.01]). 
Corresponding rates for exit-site catheter infections were 8.0 and 2.5 episodes per 1,000 venous central 
catheter-days [0.32 (0.07-1.49)], and the rates for bloodstream infections were 23.1 and 13.9 episodes 
per 1,000 venous central catheter-days, before and after interventions [0.61 (0.32-1.14)]. Conclusion: 
A prevention strategy targeted at the insertion and maintenance of vascular access can decrease rates 
of vascular-access infections in pediatric intensive care unit. 
Keywords: catheterization, central venous; intensive care units; pediatric disease prevention.
INTRODUCTION
Although central venous catheters (CVC) 
are important for the management of critical 
patients, they are not without risks. 
CVC-associated infections (CVC-AI) are im-
portant health care-associated infections in 
pediatric intensive care units (PICU), with a 
relevant impact on morbidity and mortal-
ity, also increasing hospital costs.1-9 It has been 
estimated that infections occur in 3% to 15% 
of all nontunneled inserted CVCs.4,10-12 In 
2003, CVC-associated bloodstream infec-
tions (CVC-ABSI) were the most important 
nosocomial infection in our hospital, with a 
substantial incidence density rate (2.7 BSI 
per 1,000 venous central catheter-days), higher 
than that observed in the literature. Studies per-
formed in adult intensive care units (ICU) have 
shown an important decrease in CVC-ABSI 
rates after educational intervention. However, 
little is known about pediatric settings.13-16 Given 
the importance of CVC-AI in PICU, the elevated 
rates in our PICU and the lack of literature rel-
evant to this specific population, we initiated this 
study with the purpose of determining the impact 
of an educational program aiming at decreasing 
CVC-AI in a PICU of a developing country.
METHODS
Setting
This prospective interventional and educa-
tional study was conducted in an 8-bedded, 
medical-surgical PICU in an 800-bed teach-
ing hospital of Universidade Federal de São 
Paulo, São Paulo, Brazil. All patients admitted 
to the unit for more than 24 hours between 
February and August 2004 (control period), 
September and October 2004 (intervention 
period) and November 2004 to May 2005 
(post-intervention period) were prospectively 
evaluated and enrolled in the study. Este é um artigo Open Access sob
 a licença de CC BY-NC-ND
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Data collection
Surveillance of nosocomial infection was based on the 
National Nosocomial Infection Surveillance System 
(NNISS), used in the unit since 2000, and was overseen 
by an infectious diseases pediatrician, who visited the 
unit daily during the study period.
Description of the intervention
The intervention period was implemented over a two-
month period and consisted of reviewing and updating 
unit policies and procedures concerning the insertion 
and maintenance of nontunneled CVC, based on Centers 
for Disease Control and Prevention (CDC)/Health-
care Infection Control Practices Advisory Committee 
(HIPAC) recommendations.17,18
Didactic lectures, totaling 6 hours, were given to 
physicians, fellows and nursing staff of the unit us-
ing a slide show. The most important messages were: 
(I) catheters should be inserted using maximal barrier 
recommendations; (II) all inserted catheters should be 
removed as soon as possible; (III) hub connection disin-
fection with 70% alcohol before and after manipulation; 
(IV) site insertion CVC should be protected with imper-
meable plastic during bath; (V) fundamental coopera-
tion of all unit members. No preferential site of inser-
tion was recommended.
PVPI was used to prepare the skin for insertion in 
pre-interventional and post-intervention phases, be-
cause chlorexidine was not standardized in the hospital 
during the study period.
Definition
CVC-AI were defined according to the CDC crite-
ria of 1988.19 Exit site infections were defined as ery-
thema, tenderness, induration or purulence affecting 2 
cm of the skin at the exit site of the catheter. Primary 
bloodstream infections were defined as bacteraemia (or 
fungaemia), for which there was no documented distal 
source, and included infections resulting from insertion of 
a central intravenous line. The infection was categorized ei-
ther as microbiologically documented or as clinical sepsis. 
Infections were regarded as ICU acquired infections 
if they occurred during PICU stay or within 48 hours of 
discharge from the unit.
The presence of bacteremia was defined as the iso-
lation of a pathogen from a blood culture of a patient 
with symptoms suggestive of infection. For patients with 
blood cultures from which coagulase-negative staphylo-
cocci were isolated, diagnosis of bacteremia required at 
least two positive blood cultures growing the same or-
ganism; for patients with clear evidence of sepsis and no 
other explanation for their symptoms except isolation of 
coagulase-negative staphylococci from a blood culture, 
a single positive blood culture result was considered suf-
ficient for the diagnosis of bacteremia.
Patients having only totally implantable ports or he-
modialysis catheters were excluded from the analyses.
Analysis data
Data were analyzed using STATA Version 7.0. The inci-
dence rate of CVC-ABSI, CVC-site insertion and CVC-AI 
was calculated and the relative risk (RR) in the post- 
interventional period compared with the pre-interven-
tional period was determined. A 95% confidence interval 
(CI) that did not include 1 and p-values < 0.05 were con-
sidered statistically significant.
RESULTS
During the study period, 255 patients and 2,954 patient-
days were screened. Patient characteristics are shown in 
Tables 1 and 2.
Pre-interventional and post-interventional groups 
were homogenous for the baseline variables studied, 
except for the use of immunosuppressive agents. In 
post-hoc analyses of risk factors for CVC-AI, immuno-
suppressive agents were not found to be a risk factor.
The rates of nosocomial infection (NI) were 44.4 
NI/1,000 patient-days, 33.2 NI/1,000 patient-days and 
38.2 NI/1,000 patient-days, during pre-intervention, in-
tervention and post-intervention phases, respectively. 
Two hundred and thirty-five CVC and 1,861 central 
venous catheter-days were evaluated, of which 18.7% 
had at least one associated infection. Device utilization 
was 63%, without any significant changes during the 
study.
We identified 44 CVC-associated infections during 
pre-intervention and post-intervention phases. Table 3 
shows the incidence density of catheter infections at 31.1 
episodes per 1,000 venous central catheter-days before 
interventions and 16.5 episodes per 1,000 venous central 
catheter-days after interventions [RR 0.53 (95% CI 0.28-
1.01)]. Corresponding rates for exit-site catheter infec-
tions were 8 and 2.5 episodes per 1,000 venous central 
catheter-days, respectively [0.32 (95% CI 0.07-1.49)], and 
the rates for bloodstream infections were 23.1 and 13.7 
episodes per 1,000 venous central catheter-days, before and 
after intervention [0.61 (95% CI 0.32-1.14)]. Incidence den-
sity rates observed are shown in Table 3. After the interven-
tion the density of CVC-AI dropped to 47% (p = 0.051).
The distribution of pathogens was not different 
when comparing pre- and post-interventional phases 
(Table 4). Coagulase-negative Staphylococcus (CNS) was 
the most common pathogen identified. Gram-negative 
microorganisms were the most prevalent in the unit.
No changes in the unit characteristics were observed 
throughout the study period.
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Table 1. Characteristics of the patients enrolled in the study 
   Phases
  Pre-intervention Intervention Post-intervention  p-value 
  phase phase phase
Gender    
 Female 51 (48.6%) 10 (40.0%) 46 (39.7%) 
0.383
 Male 54 (51.4%) 15 (60.0%) 70 (60.3%)  
Years (months) 26.5 (0-158) 54.0 (1-157) 15.5 (0-190) 0.371 
Parenteral nutrition    
 Yes 15 (14.2%) 2 (7.4%) 22 (18.3%) 
0.371
 No 91 (85.8%) 25 (92.6%) 98 (81.7%)  
Immunosuppression     
 Yes 55 (51.9%) 15 (55.6%) 43 (35.8%) 
0.026
 No 51 (48.1%) 12 (44.4%) 77 (64.2%)  
Outcome    
 Discharge 99 (93.4%) 23 (85.2%) 106 (90.0%) 
0.374
 Death 7 (6.6%) 4 (14.8%) 12 (10.0%)  
Death during hospital stay    
 Yes 25 (24.3%) 5 (19.2%) 25 (22.1%) 
0.907
 No 76 (73.8%) 21 (80.8%) 87 (77.0%)  
Transfer 2 (1.9%) - 1 (0.9%)  
Hospital stay (days) 6.0 (1-180) 5.5 (1-188) 5.0 (1-47) 0.159 
PIM II*
 2.58 3.10 1.85 
0.203
 
  (0.06-50.86) (0.22-58.15) (0.08-38.47)
Nosocomial infection    
 Yes 37 (34.9%) 5 (18.5%) 32 (26.7%) 
0.171
 No 69 (65.1%) 22 (81.5%) 88 (73.3%)  
Central venous catheter      
associated infection    
 Yes 20 (18.9%) 3 (11.1%) 13 (10.8%) 
0.228
 No 86 (81.1%) 24 (88.9%) 107 (89.2%)  
Central venous catheter    
 Yes 70 (66.0%) 17 (63.0%) 77 (64.2%) 
0.936
 No 36 (34.0%) 10 (37.0%) 43 (35.8%)  
p < 0.05; *Pediatric Index of Mortality II (20).
DISCUSSION
Educational intervention is recommended by the BSI-CVC 
guidelines of the Infectious Disease Society of America to 
reduce CVC-BSI rates. Apart from the fact that the litera-
ture shows an important drop in CVC-AI rates after imple-
mentation of educational programs in adults ICU,13-16 there 
is little information concerning PICU. This innovative study 
demonstrates the importance of an educational program as 
a tool to decrease CVC-AI in PICU. The decrease in CVC-AI 
seen in our study is similar to the 40% to 60% decrease ob-
tained in adult ICUs using a similar approach.13-16 Bhutta et 
al.20 showed significant decreases in rates of bloodstream in-
fections associated with catheters after the implementation 
of a similar educational program. Annual rates with CVC 
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Table 2. Underlying diseases responsible for  
patient’s hospitalization in the Pediatric Intensive 
Care Unit
  n %
Surgical 65 25.7
 Cardiac 13 5.1
 Neurosurgical 7 2.8
 Abdominal surgery 27 10.7
 Others 18 7.1
No surgical 188 74.3
 No chronic disease 26 10.3
 Pulmonary disease 18 7.1
 Intestinal disease  22 8.7
 Neurological disease 38 15.0
 Nonsurgical cardiac disease 18 7.1
 Renal disease 17 6.7
 AIDS 2 0.8
 Hematological disease 6 2.4
 Syndrome disorder 22 8.7
 Trauma 8 3.2
 Others 11 4.3
Total 253 100
Table 3. Incidence density rates during pre-intervention and post-intervention phases 
                        Pre-intervention            Post-intervention    
                       phase                               phase
 n Incidence n Incidence Density IC 95% p-value 
  density rates  density rates rates ratio
Bloodstream infection 23 23.1 11 13.9 0.61 [0.32 – 1.14] 0.166
Insertion site infection 8 8.0 2 2.5 0.32 [0.07 – 1.49] 0.124
Central venous catheter 31 31.1 13 16.5 0.53 [0.28 – 1.01] 0.051 
associated infection
Table 4. Microbiology of central venous catheter associated infections 
Microorganisms Pre-intervention phase Intervention phase Post-intervention phase
Gram-negatives 8 (57.1%) 1 (100.0%) 4 (57.1%)
Gram-positives 4 (28.6%) 0 (0%) 2 (28.6%)
Yeasts 2 (14.3%) 0 (0%) 1 (14.3%)
Total 14 (100.0%) 1 (100.0%) 7 (100.0%)
from 9.7/1,000 days in 1997 to 3.0/1,000 days in 2005, which 
translates to a relative risk reduction of 75% (95% CI 35 to 
126%), an absolute risk reduction of 6% (95% CI 2 to 10%) 
and a treatment number of 16 (195% CI 0 to 35).
The incidence density of catheter infections decreased 
substantially from 31.1 to 16.5 episodes per 1,000 venous 
central catheter-days [0.53 (95% CI 0.28-1.01)] due to a de-
creased incidence of exit-site catheter infections (8.0 to 2.5 
episodes per 1,000 venous central catheter-days) and blood-
stream infections (23.1 to 13.9 episodes per 1,000 venous 
central catheter-days).
There was no decrease in mortality and number of days 
spent in hospital between pre and post-intervention phases.
Decreasing the rate of CVC-AI is an important focus for 
quality improvement in a critical-care setting.
An important component to the success of this study was 
the strong support received from the medical and nursing 
team of the unit.
A potential limitation to this study was the use of a before 
and after study design, but during the study period there was 
no alteration in the characteristics of the unit or in clinical 
or laboratory diagnosis. The patients in the pre- and post-
intervention period were comparable in almost all measured 
variables, including risk factors for CVC-AI, except for the 
use of immunosuppressive agents, which was greater during 
the pre-interventional phase. Nonetheless, we performed a 
risk factor analysis for CVC-AI, and the use of immunosup-
pressive agents was not significant.
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Markers of changes in the caretaking process, like sys-
tematic observation of CVC insertion and care techniques as 
well as the care and manipulation of CVC, could not be col-
lected. However, the profound involvement of the unit staff 
and the presence of a specific professional throughout the 
study period probably minimized this possibility.
We developed an effective educational strategy for the 
unit staff at minimal cost by using evidence-based guide-
lines for the proper insertion and care of CVC in a PICU of 
a developing country hospital, which resulted in a reduction 
of CVC-AI rates. We believe that our findings may be ap-
plicable to other PICU.
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